Nimesulida Jabasulide (Nimesulide)

Nimesulide, the active ingredient in Nimesulida Jabasulide, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral formulation for systemic use. It is employed to relieve mild to moderate pain, reduce fever, and manage inflammatory conditions such as osteoarthritis and dysmenorrhea in adult patients.

GNH USA supplies Nimesulida Jabasulide as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for export to EU and other markets.

Nimesulide acts as an NSAID that reduces inflammation and pain by targeting cyclo‑oxygenase pathways.

Mild to moderate pain: provides analgesic relief in musculoskeletal, dental and postoperative discomfort. Fever: lowers elevated body temperature associated with infections or inflammatory states. Osteoarthritis: decreases joint inflammation and improves mobility in degenerative joint disease. Dysmenorrhea: alleviates menstrual cramps and associated pelvic pain.

Nimesulide may be associated with a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia or abdominal pain. - Headache: mild to moderate intensity. - Skin rash: mild erythema or pruritus.

Serious or Rare Side Effects: - Severe hepatic injury: hepatitis or liver failure requiring discontinuation. - Stevens‑Johnson syndrome or toxic epidermal necrolysis: severe skin reactions. - Renal impairment: acute kidney injury or reduced renal function.

When prescribing Nimesulida Jabasulide, clinicians should consider several safety measures.

Assess renal function: evaluate kidney status before initiating therapy, especially in patients with pre‑existing renal disease. Monitor hepatic parameters: perform baseline liver function tests and repeat periodically during treatment. Avoid in known hypersensitivity: discontinue if allergic reactions such as rash or swelling occur. Do not combine with other NSAIDs or anticoagulants without medical supervision: increased risk of bleeding. Pregnancy and lactation: use only if clearly needed and prescribed by a physician. Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Nimesulida Jabasulide can interact with several medicines; awareness helps prevent adverse events.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of bleeding. - Other NSAIDs or aspirin: additive gastrointestinal toxicity. - Lithium: elevated lithium levels and toxicity.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: possible reduction in renal function. - Selective serotonin reuptake inhibitors (SSRIs): modest increase in bleeding risk.